Jordana Joy, Associate Editor

Erin Rueff, OD, PhD, FAAO, details the presentation she gave at this year's conference on the importance of validating patients' symptoms in cases of neuropathic corneal pain.

Julie Rodman, OD, MS, FAAO, details a Rapid Fire session she presented at this year's American Academy of Optometry meeting, which features a case study on retinal vein occlusion.

Catch up on what happened in optometry during the week of October 28-November 1.

Comfort, vision, freedom from glasses, and convenience were cited as benefits of wearing contact lenses by survey participants.

Six topics were assessed in the report, including global data on myopia prevalence, technology, environmental and genetic contributions to myopia onset and progression, and mechanistic causes of myopia pathogenesis, among others.

Catch up on what happened in optometry during the week of October 21-October 25.

The data showed a reduction in the GA lesion growth rate of 15.3% versus placebo from 6 to 24 months and a slowing in GA growth rate of 13.4% from baseline to 24 months.

The company previously released positive data results from the pivotal Phase 3 CLARITY study in April, with the NDA submitted in August of this year.

The OCS-01 eye drops, which utilize an OPTIREACH formulation of high concentration dexamethasone, are intended to be a non-invasive topical treatment.

The study estimated that found approximately 4.22 million people in the US have glaucoma, with as many as 1.49 million people with vision-affecting glaucoma.

Catch up on what happened in optometry during the week of October 14-October 18.

The study is now expected to be fully enrolled with all 300 patients randomized by the end of 2024.

As much as 96% of customers and 60% of patients can get their results in less than a minute with Retinalyze, according to the company.

Danielle Crull, ABOM, details Truffles' story and new initiatives she has taken on to destigmatize glasses and patching for children.

According to the American Optometric Association, there are more than 7700 licensed practicing optometrists in 6 states affected by the hurricanes.

With transportation hurdles, lack of eye care providers and practices, and economic disadvantages working against rural patients, vision initiatives are getting creative to ensure they still receive care.

Catch up on what happened in optometry during the week of October 7-October 11.

MeiboMetrics is scheduled to be available on several platforms starting in 2025.

Danielle Crull, ABOM, of A Child's Eyes discusses what is now possible at her glasses dispensary that was not previously possible without Truffles.

Truffles the Kitty has helped put A Child's Eyes patients feel more at ease when being fitted with glasses while taking social media by storm.

The Eye Care Network adds a longstanding, CME-certified to its live event programming.

NextGen Healthcare's NextGen Ambient Assist is able to recognize medical acronyms and provides automation for both uploading information into the EHR and deleting audio and transcripts to ensure patient privacy is protected.

Researchers found that in the acute phase of uveitis at day 18 after disease induction, the immune cells were specifically recruited to the lens capsule.

Catch up on what happened in optometry during the week of September 30-October 4.

Reproxalap was previously found to be statistically superior to vehicle for the primary endpoint of ocular discomfort (P=0.004) in a Phase 3 randomized, double-masked, vehicle-controlled dry eye chamber clinical trial.

Opal, the new digital marketplace, will streamline contact lens ordering and allow patients and practices to order select OTC products, according to a news release.

Transitions was presented the award in the Vision category at SILMO 2024 in Paris, France.

By alternating the focus area—or the clear zone of the lens—and defocus area—the honeycomb-shaped segment of the lens—the spectacle lenses achieve clear vision and manage myopia progression.

Mark Dunbar, OD, FAAO, emphasizes the critical role optometrists play in the collaborative care of diabetic eye disease.

Ultimately, the goal is to help optometrists better understand which cases require urgent or emergent attention versus those that are more benign and can be managed over time.